Member Info for WBAFC

Can someone post up the link for AGM

Few weeks ago OBD was around £16M Market Cap

https://www.oxfordbiodynamics.com/

Wilson , their Market Cap was much lower few weeks ago. Maybe wait till their Market Cap drops

Here is more information regarding this PSE test. Novacyt need to M&A with companies like Oxford biodynamics

https://www.94percent.com/

I would like the BOD to diversify the portfolio and buy a company that is doing diagnostic tests for common cancers.

Here is a company that could be going places. They have released a 94% sensitive test for prostate cancer. Currently the PSA test is only 55% sensitive . So this new test called PSE would be a blockbuster

Oxford biodynamics on LSE as ' OBD '

Great questions Kaeren . Lets hope they answer each one properly F2F . Love to see RNS stating JW has resigned tomorrow morning.

We all realise our investment in Novacyt is at the mercy of the BOD . If they don't perform to establish this company as a profit making company then our money is lost.

Hi EXMEX , I think the Ranger technology looks great on paper , what's crucial now is translating that into big massive contracts. Who are going to give us these contracts ? NHS ? or private sector

EXMEX , I disagree , the previous LTIP sent up in 2017 for GM and his CFO was around £6 to be completed in December 2020 . That figure was totally unrealistic in December 2019 and they did not alter that LTIP then . I would imagine if after December 2024 they have not achieved the LTIP , that's when they will start a new one. Let's hope they do achieve the December 2024 LTIP and get this SP above £7

HarChris , excuse my non technical language used , I am a medic not a finance person , so yes I mean overturn £7M loss.

Realistically how much could Novacyt BOD bring Yourgene costs down ? Yourgene raised £7M last December by diluting their shareholders , and this only lasted them around 10 months before they would have had to declare bankruptcy.

Is it Realistically visible to hope that we can cut costs right down to zero ? My feeling is maybe they could cut the costs by £3M , but that still cash burn of 4M every 10 months.

* not

I checked my HL account on Tuesday gone and it stated I have noted submitted my votes for all resolutions. So for my 108,128 shares have submitted my votes again, and voted no for JW being re - elected again as chairman.

So if JW is kicked off the board , what happens next , who is likely to be chairman appointed ? Could Graham Mullis come back and be the new chairman ? Or would it be Lyn Rees ? What would happen to the SP short term ?

Why I am holding onto all my Novacyt shares is because simply when you invest in something , you invest because you believe strongly that your money is in safe hands and those in charge have immense integrity and determination of drive to succeed the company. Thats why I am praying and praying and praying that these BOD @ Novacyt are going to have enough integrity within themselves to make sure the company is successful and protect sharehder value.

David Allmond mentioned in 2022 that £10M was spent on R&D . I am eagerly waiting on the fruits of this investment and outcome. Does anyone know anything more about this R&D

What are the risks with Novacyt that are inhibiting new investment into Novacyt and to encourage institutions to come in :

1. The obvious one is the DHSC dispute , which , if Novacyt lose would destroy the company and ruin investors all their money. It would mean Novacyt would be bought out by another company at minimal cost.

2. Buying Yourgene maybe high risk . The Yourgene BOD had to raise almost 7M last December in order to survive , by diluting their share holders out , which incidentally only lasted them another 10 months before they would have become bankrupt. So if Novacyt cannot reduce Yourgene costs significantly this will result in a 7M cash burn every 8-10 months .

3. What confidence can you have in people running Novacyt when they do not protect their shareholders . I am talking more about James Wakefield , what does he actually bring to Novacyt. Then you have people like Lyn Rees who basically ruined Yourgene shareholders.

4. The appalling commerce from Novacyt.

5. The appalling appointments over the last few years of individuals such as David Allmond , the struck off dentist being in charge of R&D etc.

6. No regular up dates on R&D

What worries me about Lyn Rees is he comes across a brilliant presenter but this is what makes a great sales man . Can he actually deliver on his statements and Yourgene win massive contracts ? If it wasn't for Novacyt to pick Yourgene up then they would have been bankrupt and he ( Lyn Rees) destroyed their share holders

The other point I want to make is that who ever appointed David Allmond should not be re elected back onto the board. If it was James Wakefield , then he has failed miserably and should be sacked from his duties.

Great Post B2HS2L , a very much appreciated post and puts things in a balanced prospective.

We also do need to be mindful that if the BOD fail in their business strategy or we are unsuccessful in the DHSC case , then , just like Novacyt have swallowed up Yourgene for a fraction of what they are were worth , then other companies will do the same with Novacyt and we investors would be screwed big time.